NCT04412057 Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury Status COMPLETED Phase PHASE2
NCT04409262 A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE3
NCT04390217 LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia Status WITHDRAWN Phase PHASE2
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04382729 Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia Status UNKNOWN Phase NA
NCT04381858 Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia Status COMPLETED Phase PHASE3
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia Status COMPLETED Phase PHASE3
NCT04371601 Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 Status UNKNOWN Phase EARLY_PHASE1
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04363060 Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit Status UNKNOWN Phase PHASE3
NCT04361942 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells Status COMPLETED Phase PHASE2
NCT04352803 Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease Status NOT_YET_RECRUITING Phase PHASE1
NCT04346355 Efficacy of Early Administration of Tocilizumab in COVID-19 Patients Status TERMINATED Phase PHASE2
NCT04346147 Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 Status UNKNOWN Phase PHASE2
NCT04338568 Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study Status UNKNOWN Phase NA
NCT04332913 Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia Status UNKNOWN Phase N/A
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE3